基本情報
- 所属
- 自治医科大学 内科学講座 内分泌代謝学部門 教授
- 学位
- 博士(医学)(東京大学)
- 連絡先
- nyahagi-tky
umin.ac.jp
- 研究者番号
- 60420246
- J-GLOBAL ID
- 200901002727554646
- researchmap会員ID
- 6000006682
- 外部リンク
研究キーワード
3経歴
10-
2023年4月 - 現在
-
2011年4月 - 2023年3月
-
2008年5月 - 2011年3月
-
2007年4月 - 2008年3月
-
2005年10月 - 2007年3月
-
2003年4月 - 2005年9月
-
2000年4月 - 2003年3月
-
1996年6月 - 1997年2月
-
1995年6月 - 1996年5月
-
1994年6月 - 1995年5月
学歴
2-
1996年4月 - 2000年3月
-
1988年4月 - 1994年3月
委員歴
8-
2024年5月
-
2019年10月
-
2017年10月
-
2016年10月
-
2016年4月
受賞
4主要な論文
155-
Biochemical and Biophysical Research Communications 739 150594-150594 2024年12月 査読有り最終著者責任著者
-
The FEBS journal 2023年9月13日 査読有り最終著者責任著者During periods of fasting, the body undergoes a metabolic shift from carbohydrate utilization to the use of fats and ketones as an energy source, as well as the inhibition of de novo lipogenesis and the initiation of gluconeogenesis in the liver. The transcription factor sterol regulatory element-binding protein-1 (SREBP-1), which plays a critical role in the regulation of lipogenesis, is suppressed during fasting, resulting in the suppression of hepatic lipogenesis. We previously demonstrated that the interaction of fasting-induced Kruppel-like factor 15 (KLF15) with liver X receptor serves as the essential mechanism for the nutritional regulation of SREBP-1 expression. However, the underlying mechanisms of KLF15 induction during fasting remain unclear. In this study, we show that the glucocorticoid receptor (GR) regulates the hepatic expression of KLF15 and, subsequently, lipogenesis through the KLF15-SREBP-1 pathway during fasting. KLF15 is necessary for the suppression of SREBP-1 by GR, as demonstrated through experiments using KLF15 knockout mice. Additionally, we show that GR is involved in the fasting response, with heightened binding to the KLF15 enhancer. It has been widely known that the hypothalamic-pituitary-adrenal (HPA) axis regulates the secretion of glucocorticoids and plays a significant role in the metabolic response to undernutrition. These findings demonstrate the importance of the HPA-axis-regulated GR-KLF15 pathway in the regulation of lipid metabolism in the liver during fasting.
-
BMC Geriatrics 23(1) 74-74 2023年2月4日 査読有り最終著者責任著者Abstract Background Mild cognitive impairment (MCI) is not just a prodrome to dementia, but a very important intervention point to prevent dementia caused by Alzheimer's disease (AD). It has long been known that people with AD have a higher frequency of falls with some gait instability. Recent evidence suggests that vestibular impairment is disproportionately prevalent among individuals with MCI and dementia due to AD. Therefore, we hypothesized that the measurement of balance capability is helpful to identify individuals with MCI. Methods First, we developed a useful method to evaluate balance capability as well as vestibular function using Nintendo Wii balance board as a stabilometer and foam rubber on it. Then, 49 healthy volunteers aged from 56 to 75 with no clinically apparent cognitive impairment were recruited and the association between their balance capability and cognitive function was examined. Cognitive functions were assessed by MoCA, MMSE, CDR, and TMT-A and -B tests. Results The new balance capability indicator, termed visual dependency index of postural stability (VPS), was highly associated with cognitive impairment assessed by MoCA, and the area under the receiver operating characteristic (ROC) curve was more than 0.8, demonstrating high sensitivity and specificity (app. 80% and 60%, respectively). Conclusions Early evidence suggests that VPS measured using Nintendo Wii balance board as a stabilometer helps identify individuals with MCI at an early and preclinical stage with high sensitivity, establishing a useful method to screen MCI.
-
Biochemical and biophysical research communications 582 35-42 2021年12月10日 査読有り最終著者責任著者High protein diet (HPD) is an affordable and positive approach in prevention and treatment of many diseases. It is believed that transcriptional regulation is responsible for adaptation after HPD feeding and Kruppel-like factor 15 (KLF15), a zinc finger transcription factor that has been proved to perform transcriptional regulation over amino acid, lipid and glucose metabolism, is known to be involved at least in part in this HPD response. To gain more insight into molecular mechanisms by which HPD controls expressions of genes involved in amino acid metabolism in the liver, we performed RNA-seq analysis of mice fed HPD for a short period (3 days). Compared to a low protein diet, HPD feeding significantly increased hepatic expressions of enzymes involved in the breakdown of all the 20 amino acids. Moreover, using KLF15 knockout mice and in vivo Ad-luc analytical system, we were able to identify Cth (cystathionine gamma-lyase) as a new target gene of KLF15 transcription as well as Ast (aspartate aminotransferase) as an example of KLF15-independent gene despite its remarkable responsiveness to HPD. These findings provide us with a clue to elucidate the entire transcriptional regulatory mechanisms of amino acid metabolic pathways.
-
iScience 24(12) 103446-103446 2021年12月 査読有り責任著者KLF15 is a transcription factor that plays an important role in the activation of gluconeogenesis from amino acids as well as the suppression of lipogenesis from glucose. Here we identified the transcription start site of liver-specific KLF15 transcript and showed that FoxO1/3 transcriptionally regulates Klf15 gene expression by directly binding to the liver-specific Klf15 promoter. To achieve this, we performed a precise in vivo promoter analysis combined with the genome-wide transcription-factor-screening method "TFEL scan", using our original Transcription Factor Expression Library (TFEL), which covers nearly all the transcription factors in the mouse genome. Hepatic Klf15 expression is significantly increased via FoxOs by attenuating insulin signaling. Furthermore, FoxOs elevate the expression levels of amino acid catabolic enzymes and suppress SREBP-1c via KLF15, resulting in accelerated amino acid breakdown and suppressed lipogenesis during fasting. Thus, the FoxO-KLF15 pathway contributes to switching the macronutrient flow in the liver under the control of insulin.
-
F1000Research 10 51-51 2021年2月 査読有り筆頭著者責任著者The identification of upstream transcription factors regulating the expression of a gene is generally not an easy process. To facilitate this task, we constructed an expression cDNA library named Transcription Factor Expression Library (TFEL), which is composed of nearly all the transcription factors in the mouse genome. Genome-wide screening using this library (TFEL scan method) enables us to easily identify transcription factors controlling any given promoter or enhancer of interest in a chromosomal context-dependent manner. Thus, TFEL scan method is a powerful approach to explore transcriptional regulatory networks.
-
FEBS letters 593(4) 423-432 2019年2月 査読有り責任著者
-
Diabetes Care 41(6) 1218-1226 2018年6月1日 査読有り最終著者
-
FEBS Letters 592(3) 422-433 2018年2月1日 査読有り責任著者
-
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 493(1) 40-45 2017年11月 査読有り最終著者責任著者
-
FEBS Letters 591(7) 965-978 2017年4月1日 査読有り責任著者
-
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 24(1) 14-18 2017年 査読有り筆頭著者最終著者責任著者
-
CELL REPORTS 16(9) 2373-2386 2016年8月 査読有り責任著者
-
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 465(4) 857-863 2015年10月 査読有り最終著者責任著者
-
NATURE COMMUNICATIONS 4 2316 2013年12月 査読有り責任著者
-
JOURNAL OF BIOLOGICAL CHEMISTRY 285(15) 11681-11691 2010年4月 査読有り責任著者
-
JOURNAL OF BIOLOGICAL CHEMISTRY 283(30) 21220-21229 2008年7月 査読有り
-
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 363(2) 329-335 2007年11月 査読有り
-
NATURE MEDICINE 13(10) 1193-1202 2007年10月 査読有り
-
JOURNAL OF LIPID RESEARCH 48(7) 1581-1591 2007年7月 査読有り
-
NATURE MEDICINE 12(1) 107-113 2006年1月 査読有り
-
JOURNAL OF BIOLOGICAL CHEMISTRY 280(30) 27523-27532 2005年7月 査読有り
-
EUROPEAN JOURNAL OF CANCER 41(9) 1316-1322 2005年6月 査読有り筆頭著者
-
In Berger A and Roberts MA (ed.), Unraveling Lipid Metabolism with Microarrays 237-248 2005年1月 査読有り筆頭著者
-
JOURNAL OF BIOLOGICAL CHEMISTRY 279(20) 20571-20575 2004年5月 査読有り筆頭著者
-
NATURE CELL BIOLOGY 6(4) 351-357 2004年4月 査読有り
-
DIABETES 53(3) 560-569 2004年3月 査読有り
-
HEPATOLOGY 38(6) 1529-1539 2003年12月 査読有り
-
JOURNAL OF BIOLOGICAL CHEMISTRY 278(28) 25395-25400 2003年7月 査読有り筆頭著者
-
JOURNAL OF BIOLOGICAL CHEMISTRY 277(22) 19353-19357 2002年5月 査読有り筆頭著者
-
JOURNAL OF BIOLOGICAL CHEMISTRY 274(50) 35832-35839 1999年12月 査読有り
-
JOURNAL OF BIOLOGICAL CHEMISTRY 274(50) 35840-35844 1999年12月 査読有り筆頭著者
MISC
141主要な書籍等出版物
66主要な講演・口頭発表等
54共同研究・競争的資金等の研究課題
18-
日本学術振興会 科学研究費助成事業 2024年4月 - 2027年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(B) 2022年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(B) 2019年4月 - 2024年3月
-
日本学術振興会 挑戦的萌芽研究 2016年4月 - 2018年3月
-
日本学術振興会 基盤研究(B) 2015年 - 2017年